COVID-19 induces coagulopathy manifested as elevation of dimerized plasmin fragment D (D-dimer) levels.1,2,3,4,5 As a result, patients with COVID-19 frequently experience both arterial thromboembolism (ATE) and venous thromboembolism (VTE). This evidence concerns the gene PLG and venous thromboembolism.